Loading…

HL-049: Clinical Relevance of NKT Cells and Soluble MIC-A in Hodgkin Lymphoma

The majority of Hodgkin lymphoma (HL) patients achieve response after treatment, but 5%–10% of them become refractory. It is very important in this fraction of patients to understand the mechanisms used by malignant cells to avoid the anti-tumoral immune response and, consequently, the development o...

Full description

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2021-09, Vol.21, p.S370-S370
Main Authors: Ojeda, Jorge Vela Ojeda Vela, Perez-Retiguin, Flor, Olivas-Bejarano, Ana Cristina, Garcia-Ruiz, Myriam, Garcia-Chavez, Jaime, Majluf-Cruz, Abraham, Reyes-Maldonado, Elba, Montiel-Cervantes, Laura
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The majority of Hodgkin lymphoma (HL) patients achieve response after treatment, but 5%–10% of them become refractory. It is very important in this fraction of patients to understand the mechanisms used by malignant cells to avoid the anti-tumoral immune response and, consequently, the development of resistance to any treatment modality. Studies trying to analyze the number and function of lymphocyte subsets in peripheral blood are limited. Evaluate the number of peripheral blood lymphocyte subsets, and soluble (s)MIC-A/B, in patients with newly diagnosed HL. Peripheral blood (SP) in EDTA from patients diagnosed with HL was taken prior to the start of treatment. Healthy donors (SD) were included as controls. By flow cytometry, using monoclonal antibodies, lymphocyte subpopulations were determined, and, by ELISA, the levels of sMICA and sMICB were determined. Statistical analysis was performed using SPSS software. Thirty-six patients with de novo HL (N=36) and 72 donors were included. Patients were of both genders, over 18 years old, with informed consent, never treated with chemotherapy, and without contaminating viral disease. There were no interventions, only samples taken as described above. CD4 T lymphocytes, B-cells, monocytes, NK, and NKT cells were decreased in patients; γ-δ T cells and soluble MIC-A serum levels were increased. Overall survival (OS) was better in patients with sMIC-A values < 100 ng/mL and NKT cells < 40 mL. Peripheral blood CD4 T lymphocytes, B cells, monocytes, NK, and NKT cells were decreased in patients with HL; s-MIC-A and γ-δ T cells were increased. s-MIC-A and peripheral blood NKT cells had clinical relevance for OS. These findings may contribute to explain, at least in part, the many different mechanisms of tumor escape from immune surveillance in this disease.
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(21)01847-4